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Background: Locomotor training using robots is increasingly being used for rehabilitation to reduce manpower
and the heavy burden on therapists, and the effectiveness of such techniques has been investigated. The robot suit
Hybrid Assistive Limb (HAL) has been developed to rehabilitate or support motor function in people with
disabilities. The HAL provides motion support that is tailored to the wearer’s voluntary drive. We performed a pilot
clinical trial to investigate the feasibility of locomotor training using the HAL in chronic stroke patients, and to
examine differences between two functional ambulation subgroups.
Methods: Sixteen stroke patients in the chronic stage participated in this study. All patients were trained with the
HAL over 16 sessions (20–30 min/day within 2 days/week). Primary outcomes were walking speed, cadence, and
number of steps recorded during a 10-meter walk test (10MWT). Berg balance scale (BBS) and timed up and go
(TUG) were also measured. All outcome measures were evaluated without wearing HAL assistance before and after
the intervention in all patients as well as in the dependent ambulatory and independent ambulatory subgroups.
Results: All participants completed the intervention with no adverse events. Gait speed, cadence, number of steps
during the 10MWT, and BBS increased significantly from 0.41 m/s to 0.45 m/s (P = 0.031), from 68.6 steps/min to
72.0 steps/min (P = 0.020), from 37.5 steps to 33.1 steps (P = 0.017), and from 40.6 to 45.4 (P = 0.004) respectively.
The TUG test score improved, although this difference was not statistically significant. The findings in the
dependent ambulatory subgroup primarily contributed to the significant differences observed in the group as
a whole.
Conclusions: This pilot study showed that locomotor training using the HAL is feasible for chronic stroke patients.
Randomized controlled trials are now required to demonstrate the effectiveness of HAL-based rehabilitation over
conventional therapies.
Trial registration: UMIN000002969Background
Stroke is the second largest cause of death in the world
[1] and is a major cause of paralysis and other physical
or cognitive disabilities [2-4]. Patients with impaired
walking ability caused by lower-limb paralysis often be-
come dependent on a wheelchair or may even be bed-
ridden [5]. Therefore, restoration of walking ability is
extremely important for maintaining or regaining qua-
lity of life, as well as activities of daily living and social
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2Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
Full list of author information is available at the end of the article
© 2013 Kawamoto et al.; licensee BioMed Cen
Commons Attribution License (http://creativec
reproduction in any medium, provided the orTask-specific training programs that improve the
motor function by motor learning of a repeatedly exe-
cuting motor task are increasingly being adopted as ad-
vanced therapy for central nervous system diseases,
including stroke [6]. Locomotor training based on gait
motion has been suggested for task-specific training
programs aimed at restoring walking ability [7-9]. In-
deed, body weight-supported treadmill training is
widely used in clinical research [10-12]. Partial body
weight support makes it easier to maintain an upright
posture by reducing the weight load on the lower limbs.
Swinging the legs with manual assistance from the the-
rapists can also allow patients with significant deficits totral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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method requires extensive manpower and places a
heavy burden on the therapists. In such procedures, one
or two therapists are positioned on one side or both
sides of the treadmill to manually assist leg motion,
which also causes fatigues in the therapist.
To overcome this limitation, robots have been deve-
loped to support gait motion. Compared with therapists,
robots are better able to provide cyclic support of the
patient’s leg motion: in therapists, excessive fatigue is
imposed because of repeated manual support that de-
mands a significant amount of energy [13]. The thera-
pists, who are now released from that heavy burden,
can then give the patients valuable advice and/or gui-
dance for locomotor training.
So far, two types of robots have been developed for
gait training. The first type involves an exoskeleton (e.g.
Lokomat [14], LOPES, ALEX [15], and AutoAmbulator
[16]), which has leg joints that match those of the pa-
tient’s legs and are positioned next to them. Actuators
placed at the joints of the robot control joint motions to
mimic normal walking patterns, and allow the patient’s
joints to move in synchronization with the robot’s
motion. The second type of robot is the end-effector
type (e.g., Gait Trainer [17], Haptic Walker [18], and
LokoHelp [19]), in which only the patient’s soles are
fixed to the robot’s foot plates. With these robots, the
motion of the robot’s foot plates mimics normal gait and
guides the patient’s feet.
Several clinical trials of robot-assisted gait training
have been conducted in stroke patients. Randomized
controlled studies for the Lokomat [20-25] and the Gait
Trainer [26-29] showed various degrees of effectiveness
of gait restoration compared with therapist-assisted gait
training or conventional therapy. Pilot clinical trials for
the AutoAmbulator [16] and the LokoHelp [19] have
also been conducted. These robots provide autonomous
motion to patients based on a desired kinematic trajec-
tory of the lower limb joints or the end effector, mimick-
ing the walking motion of an able-bodied person [14,17].
To date, however, robot-based rehabilitation of walking
has concentrated on locomotor training using the au-
tonomous motion generated by the robots.
We developed the Hybrid Assistive Limb (HAL), a
wearable robot that interactively provides motion
according to the wearer’s voluntary drive [30]. The HAL
detects the bioelectric signals generated by patient’s
muscle activities and/or the floor reaction force signals
caused by patient’s intended weight shifts. The HAL en-
ables locomotor training with voluntary drive. HAL has
the advantage of voluntary drive and ambulatory per-
formance. The other exoskeletons use autonomously
generated predefined motion for users. In contrast, HAL
generates motion according to the wearer’s voluntarydrive. The wearer operates the HAL by adjusting his/her
muscle activities. Therefore, the HAL is able to conduct
locomotor training by providing motion support in re-
sponse to the user’s voluntary drive. This assistance
mechanism is completely different from those of other
exoskeletons. In addition, the other exoskeletons are
designed for walking on a treadmill; therefore, they pro-
vide a simulated gait that differs from that of walking
on a flat floor. In contrast, as a wearable system, the
HAL delivers locomotor training in actual ambulatory
environment. Kubot et al. reported that for patients
with limited mobility including chronic stroke, gait
speed increased after gait training with the HAL [31].
In this study, gait speed increases were significant for
nine patients with chronic stroke. However, the feasibi-
lity of HAL-based training for improving walking ability
or balance, and its benefits for patients with chronic
stroke are unclear; therefore, preliminary data are
needed before conducting randomized controlled trials
to confirm its effectiveness. We conducted a pilot cli-
nical trial to investigate the feasibility of locomotor
training with the HAL in chronic stroke patients and to




Sixteen stroke patients with hemiplegia (12 men and four
women) participated in this study (Table 1). The mean ±
standard deviation (SD) age at the time of study enrol-
ment was 61.0 ± 14.8 years. All patients were in the
chronic phase (time since stroke: 47.1 ± 37.6 months)
enrolling in the study > 6 months after the first stroke
and currently enrolled in physical therapy. The causes of
stroke were hemorrhage (n = 12), ischemia (n = 2), ische-
mia and subarachnoid hemorrhage (n = 1), and moyamoya
disease (n = 1). Seven patients had left-sided paralysis,
while nine had right-side paralysis. Twelve were classified
as Brunnstrom stages III, while the others were characte-
rized as I, II, IV, and V (one each). Before the interven-
tion, ten patients used a T-cane to walk, three used a
quad-cane, and one used a pick-up walker. Twelve wore
ankle foot orthoses, while one wore a knee ankle foot
orthosis. Four patients were able to walk independently,
five needed supervision during walking, and one was
unable to walk. The mean Barthel index was 83.8 ± 15.0.
All patients except for Cases 7, 8, and 15, underwent con-
ventional rehabilitation or exercise instruction before this
study. We divided the patients into two subgroups based
on Functional Ambulation Category (FAC): a dependent
ambulatory subgroup, in which eight patients required
assistance from another person in the form of intermit-
tent or continuous light touch to assist balance or co-
ordination (FAC 2), or stand-by guarding or verbal
Table 1 Patient characteristics
Case Sex Age Time since
stroke, months
Etiology Side of paralysis Br. stage Assistive device Orthosis FAC BI Group
1 M 65 26 Hemorrhage R III Quad-cane AFO 3 50 A
2 M 72 33 Ischemia L III T-cane AFO 3 75 A
3 M 54 13 Hemorrhage L III T-cane NA 3 80 A
4 F 63 27 Hemorrhage R III T-cane AFO 3 90 A
5 M 18 132 Moyamoya disease L IV NA AFO 5 100 B
6 M 74 42 Ischemia L III T-cane AFO 4 100 B
7 M 53 24 Ischemia, Subarachnoid
hemorrhage
R I Pick-up walker KAFO 2 65 A
8 M 64 13 Hemorrhage R III T-cane AFO 3 80 A
9 F 67 40 Hemorrhage R V T-cane NA 5 90 B
10 F 64 84 Hemorrhage L III T-cane AFO 4 70 B
11 M 61 40 Hemorrhage L III NA NA 4 85 B
12 M 67 48 Hemorrhage R III Quad-cane AFO 3 70 A
13 F 45 18 Hemorrhage R III Quad-cane AFO 4 85 B
14 M 84 56 Hemorrhage R III T-cane AFO 4 100 B
15 M 55 25 Hemorrhage L III T-cane AFO 4 100 B
16 M 70 132 Hemorrhage R II T-cane AFO 3 100 A
M male, F female, L left, R right, Br. Brunnstrom, AFO ankle foot orthosis, KAFO knee ankle foot orthosis, NA not applicable, FAC functional ambulation categories,
BI Barthel index, Group A dependent ambulatory, Group B independent ambulatory.
Kawamoto et al. BMC Neurology 2013, 13:141 Page 3 of 8
http://www.biomedcentral.com/1471-2377/13/141cueing (FAC 3), and an independent ambulatory subgroup
in which eight patients could walk freely on level surfaces
only (FAC 4) or everywhere independently (FAC 5).
The inclusion criteria were as follows: requirement of
physical assistance or assistive devices for standing up,
sitting down, and/or walking; understanding an expla-
nation of the study protocol and expressing voluntary
consent or refusal; a body shape that could fit in the ro-
botic suit HAL (height, 150–180 cm; weight ≤80 kg);
and concurrent use of physical and occupational the-
rapies. Exclusion criteria were uncontrolled cardiorespi-
ratory conditions, severe cognitive deficits affecting the
ability to understand verbal instructions, severe con-
tractures limiting the range of motion of the lower limb
(loss of hip or knee extension >20°), and severe spasti-
city (Modified Ashworth Scale score >3). All patients
provided written informed consent, including allowing
the publication of individual clinical details, before
participating in the study, which was approved by the
institutional review board at the University of Tsukuba.
This study was part of a research project whose proto-
col was registered with the UMIN Clinical Trials
Registry (UMIN000002969).
Intervention
All patients underwent 16 locomotor training sessions
using the HAL within 2 days/week as tolerated by
each patient. Each session lasted approximately90 min, including setup of the HAL, rest periods, and
assessments. The total duration of training with the
HAL was between 20 and 30 min in each session.
During locomotor training, the patients walked on a
floor with robotic assistance from the HAL. To pre-
vent falling, the patients wore a harness connected to a
mobile suspension system (All-In-One Walking Trainer,
Ropox A/S, Denmark) (Figure 1). The level of suspension
was independently adjusted for each patient and in-
creased as tolerated without excessive knee flexion du-
ring the stance phase or toe dragging during the swing
phase. A therapist operated the suspension system to de-
termine the walking speed and direction. Another the-
rapist was positioned behind the patient to support hip
and trunk stability if needed. As shown in Figure 1, the
patients were allowed to hold onto the side rails of the
suspension system to maintain their posture.
Early training sessions for individuals with severe gait
impairment involved simple flexion/extension move-
ments of the lower limb and dynamic postural tasks (i.e.,
sit-to-stand task) with HAL assistance to become famil-
iar with operating HAL and receiving its assistance
before progressing to walking training with it. The
walking speed and distance during training were deter-
mined based on the patient’s tolerance. As the session
progressed, the training intensity was gradually increased
by changing the walking speed, duration of walking, and
the degree of the body-weight unloading. The therapists
Figure 1 Photograph showing the Hybrid Assistive Limb (HAL)
worn by a patient and the All-In-One Walking Trainer
suspending the patient during the locomotor training.
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tients regarding walking pattern and posture. Blood
pressure and heart rate were measured at the start and
end of each training session, and during the rest periods.
At the end of each session, the patients stated their fa-
tigue level after the training as well as their level of
satisfaction with the robotic assistance during move-
ment by using a visual analog scales.
During each training session, walking was continu-
ously assisted by the HAL, a computer-controlled exo-
skeletal device. The design and control system for the
HAL are described in more detail elsewhere [30]. Briefly,
the exoskeletal frame was secured to the patients at the
pelvis and at the lower limbs by cuffs. The joints of the
HAL frame were aligned to the patient’s joints. Active
joints-mounted actuators generated assistive torque at
the hip and knee joints. The HAL has a hybrid control
system consisting of a Cybernic Voluntary Control
(CVC) and a Cybernic Autonomous Control (CAC) [30].
The CVC drives the amount and timing of the assistive
torque provided to each joint for walking based on bio-
electrical signals detected from skin surface electrodesplaced over the flexor and extensor muscles of the hip
and knee [32]. The gain in assistive torque at each joint
in response to the bioelectrical signals was controlled by
a therapist. The optimal gain and balance of the torque
to maintain an appropriate walking pattern were deter-
mined by observing the joint trajectories and patient’s
comments. If it was difficult for patients to achieve the
motion derived from the CVC, the CAC can autono-
mously generate torque according to the walking pattern
by referring to information from the floor reaction force
[33] and was used until the patients became familiar
with the CVC.
Outcome measures
Outcome measures were collected for each participant
before and after the HAL locomotor training. As a pri-
mary outcome measure, walking speed was assessed by
the 10-meter walk test (10MWT), in which gait speed is
sensitive to changes in locomotor recovery in chronic
stroke patients [34,35]. The number of steps and ca-
dence during the 10MWT were also assessed. Gait speed
is a combination of stride length and cadence [36]. In
the present study, the number of steps related to stride
length was used. For the 10MWT, all patients walked
without HAL assistance on a flat surface at a comfort-
able self-selected walking speed. They started walking
before the starting line for the 10-m distance to acceler-
ate and attain a stable speed before the test. To calculate
walking speed, the walking time for 10 m was measured
using a stopwatch. The number of steps was also
counted for 10 m. During the measurement, the patients
were allowed to use their assistive device and/or lower-
limb orthosis as necessary. Therapists closely guarded
the patients during the 10MWT against falls, for ex-
ample, but did not provide physical assistance. Patients
were required to use the same device and/or orthosis at
the pre- and post-intervention measurements. The pa-
tients performed the 10MWT twice at each measure-
ment. The best time of the two trials was used in the
analysis [31]. Cadence was calculated as the number of
steps divided by the walking time (steps/min).
The Berg balance scale (BBS) for balance function and
3-m timed up and go (TUG) test were determined be-
fore and after the intervention as other primary out-
comes. For the BBS, 14 functional tasks were rated on a
5-point scale from 0 (lowest level of function) to 4
(highest level of function) by a therapist. The total scores
ranged from 0 (severely impaired balance) to 56 (excel-
lent balance). For the TUG, patients stood up from an
armchair, walked 3 m, returned to the chair, and sat
down using walking aids as required. This test assesses
the patient’s dynamic balance ability and is a reliable and
valid measure for stroke patients [37]. The best time of
two trials was used in the analysis [38].
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Data are shown as means ± SD. To evaluate the feasibi-
lity of locomotor training using the HAL, the outcome
measures were compared between pre- and post-
training using a paired Wilcoxon’s test. The level of sta-
tistical significance for all measures was set at P < 0.05.
The effect size (Cohen’s d) was calculated as the mean
difference divided by the SD. A d value of 0.2 is consi-
dered a small effect size, 0.5 a medium effect size, and
0.8 a large effect size [39]. All statistical analyses were
performed using SPSS software version 17.0 (SPSS Inc.,
Chicago, IL, USA).
Results
All of the patients completed all 16 sessions. The CVC
was used during locomotor training with the HAL in
most patients. The CAC was used for the left knee joint
in Case 4 between session 8 and session 12, because the
motion provided by the CVC was slightly awkward for
the patient. No training-related serious adverse events
were observed.
The mean duration of the intervention period was
10.8 ± 3.5 weeks in all patients. The patient in Case 5
took 21 weeks to complete the intervention for his per-
sonal reasons, and his data were excluded from the ana-
lyses because of the deviation from the protocol. The
patient in Case 4 needed to rest for 1 month after ses-
sion 15 because of knee pain (patellar tendinitis); how-
ever, she completed the final session and her data were
included in the analyses. Therefore, the 10MWT and
BBS were evaluated in 15 patients, whereas the TUG test
was evaluated in 14 patients. The patient in Case 7 expe-
rienced a physical burden, which was not able to tole-
rable for the TUG test.
The mean differences in walking speed, cadence, and
number of steps for the group as a whole were 0.04 ±
0.11 m/s (P = 0.031, d = 0.34), 3.3 ± 13.3 steps/min (P =
0.017, d = 0.25) and −4.4 ± 8.0 steps (P = 0.020, d = 0.55),
respectively (Table 2). The mean changes in BBS and
TUG were 4.8 ± 7.0 (P = 0.004, d = 0.68) and −1.0 ± 4.7 s
(P = 0.551, d = 0.22), respectively (Table 2).Table 2 Comparison of outcomes between the start and
end of the Hybrid Assistive Limb-assisted training
program for the group as a whole
Outcome measurements Before training After training N
10MWT Speed (m/s) 0.41 ± 0.26 0.45 ± 0.24* 15
Cadence (steps/min) 68.6 ± 26.4 72.0 ± 20.1* 15
Number of steps (steps) 37.5 ± 22.7 33.1 ± 20.0* 15
BBS 40.6 ± 13.6 45.4 ± 8.02* 15
TUG (s) 36.0 ± 30.9 34.9 ± 29.5 14
Values are means ± standard deviation.
*Pre-post difference, P < 0.05.
10MWT 10-m walk test, TUG Timed-up and go. BBS Berg balance scale;co.For the dependent ambulatory subgroup, the mean
differences in walking speed, cadence, and number of
steps were 0.07 ± 0.04 m/s (P = 0.012, d = 1.65), 7.5 ± 5.9
steps/min (P = 0.017, d = 1.26) and −8.0 ± 9.7 steps (P =
0.027, d = 0.82), respectively (Table 3). The mean
changes in BBS and TUG were 7.0 ± 9.0 (P = 0.034, d =
0.78), and −2.9 ± 5.2 s (P = 0.237, d = 0.56), respectively
(Table 3). For the independent ambulatory subgroup,
the mean differences in walking speed, cadence, and
number of steps were 0.005 ± 0.15 m/s (P = 0.612, d =
0.004), -1.4 ± 18.0 steps/min (P = 0.237, d = 0.08) and
−0.29 ± 1.8 steps (P = 0.671, d = 0.16), respectively
(Table 3). The mean changes in BBS and TUG were 2.3 ±
2.4 (P = 0.050, d = 0.94) and 0.9 ± 3.9 s (P = 0.398, d =
0.26), respectively (Table 3).
Discussion
The aim of the present study was to investigate the
feasibility of locomotor training using the HAL for im-
proving walking ability and balance in chronic stroke
patients. The intervention significantly improved gait
speed, cadence, and the number of steps assessed by
the 10MWT as well as the BBS score. The TUG time
also improved, although this difference was not statisti-
cally significant. The results obtained in this pilot cli-
nical trial suggest that a HAL walking training program
can improve walking speed, mainly in terms of both of
cadence and the number of steps, and improve the ba-
lance ability on the basis of BBS.
To further investigate our findings on the feasibility of
locomotor training using the HAL, we explored how the
subgroups based on functional ambulation influenced the
results. The dependent ambulatory subgroup displayed
significant differences in walking speed, cadence, and
number of steps between before and after the HAL train-
ing, with large effect sizes (d > 0.8). In contrast, these
differences were not significant for the independent am-
bulatory subgroup. Although the difference in BBS score
was statistically significant in both subgroups, the effect
size in the dependent ambulatory subgroup (d > 0.8) was
lager than in the independent ambulatory subgroup (d <
0.3). These findings indicate that the differences in walk-
ing speed, cadence, and number of steps of the group as a
whole was primarily because of those in the dependent
ambulatory subgroup.
Several studies have investigated the effects of loco-
motor training using robots for chronic stroke patients.
Using the Lokomat, Hornby et al. [22] reported a
0.07 m/s increase (d = 1.0) in gait speed from the mean
baseline value of 0.45 m/s. Similarly, Westlake & Patten
[25] reported a 0.1-m/s increase (d = 0.32) from the
mean baseline value of 0.62 m/s. Using other robots,
Peurala et al. reported a mean increase in walking speed
of 0.08 m/s from the mean baseline value of 0.25 m/s
Table 3 Comparison of outcomes between the start and end of the Hybrid Assistive Limb-assisted training program for
the subgroups
Outcome measurements Dependent ambulator Independent ambulator
Before training After training n Before training After training n
10MWT Speed (m/s) 0.24 ± 0.16 0.30 ± 0.19* 8 0.60 ± 0.21 0.60 ± 0.19 7
Cadence (steps/min) 52.9 ± 14.4 60.4 ± 16.4* 8 86.5 ± 26.1 85.1 ± 18.2 7
Number of steps (steps) 48.9 ± 26.6 40.9 ± 18.8* 8 24.4 ± 2.88 24.1 ± 3.18 7
BBS 33.6 ± 15.6 40.6 ± 8.07* 8 48.6 ± 3.31 50.9 ± 3.02* 7
TUG (s) 53.4 ± 35.8 50.5 ± 35.5 7 18.5 ± 8.58 19.4 ± 7.52 7
Values are means ± standard deviation.
*Pre-post difference, P < 0.05.
10MWT 10-m Walk Test, TUG Timed-up and go. BBS Berg balance scale.
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from 0.23 m/s at baseline using the Gait Trainer with
functional electrical stimulation [28]. It is difficult to
compare these studies with the present study because of
differences in baseline walking ability and study settings.
However, the increase in walking speed after the HAL
training program in the dependent ambulatory subgroup
(0.07-m/s increase from the mean baseline of 0.24 m/s,
d = 1.64) is consistent with the result of locomotor trai-
ning with other robots.
In recent years, a top-down approach has emerged as
a new rehabilitative methodology. Belda-Lois et al. de-
fined this approach as rehabilitation therapies based on
the state of the brain instead of the bottom-up approach,
which acts on the physical level [40]. The top-down ap-
proach is considered highly promising from the view-
point of neurorehabilitation because it promotes
neuroplasticity. This approach is mainly applied in func-
tional electrical stimulation, assistive robotic devices,
and brain–computer interfaces that use myoelectric or
brain activity during the patient’s volitional control.
Locomotor training using the HAL is based on the top-
down approach. The HAL assists motion by myoelectric
activity on the basis of the patient’s voluntary drive. The
voluntary drive and thus the motion normalized by the
assistance provided by the external device forms the
foundation for a proprioceptive feedback loop for pa-
tients with lesions involving the sensory pathways. The
neural activity associated with voluntary drive and nor-
malized motion while repeatedly and intensively execut-
ing specific tasks promotes learning [41] and then leads
to the reinstatement or restructuring of appropriate pro-
prioceptive feedback. This mechanism explains the
therapeutic effect of locomotor training using HAL as
one of these top-down approaches.
Some robots have been used for active training during
walking rehabilitation. The Lokomat autonomously pro-
vides a predefined walking motion that is not related
to the user’s voluntary drive. The user generates force
along the autonomous motion pattern generated by theLokomat and is encouraged to generate as much effort
as possible [20-23]. In contrast, the HAL generates as-
sistive torque according to the amount of the bioelectric
signals generated the user’s voluntary muscle activities.
The user obtains motion assistance while simultaneously
operating HAL on the basis of the user’s voluntary drive
[32]. Therefore, the user is able to control the amount of
assistance provided by HAL by voluntarily adjusting
their myoelectric activities. As mentioned above, this
mechanism forms a proprioceptive feedback loop. A vis-
ual feedback loop would be also formed because the pa-
tients are able to directly observe the supported motion.
Therefore, the user makes effort to produce the inter-
active motion as close as possible to the motion pattern
of normal gait by using the perceptual feedback. This
process might improve the gait patterns of patients with
chronic stroke. As a result, the locomotor performance
differed significantly before and after the HAL training.
To our knowledge, the present study was the first to in-
vestigate the feasibility of the locomotor training with
the interactive motion provided by the HAL and under
voluntary user control.
Randomized controlled trials are now needed to con-
firm the efficacy of HAL-assisted training compared with
conventional physical therapy. Studies are also needed to
examine the characteristics of patients who experience
the greatest benefits with HAL-assisted locomotor trai-
ning by examining features such as walking ability or
severity of paralysis at baseline. Studies should also de-
termine the optimal frequency and duration of the
HAL-assisted training. Information analysis on these
studies are essential to develop the most effective opera-
ting procedures to enable therapists to adjust the
amount of interactive motion provided by the HAL
according to the user’s voluntary drive.
Conclusions
In this study, we confirmed the feasibility of HAL-assisted
locomotor training for chronic stroke patients. It is inter-
esting to note that the findings in the dependent
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cant differences. This study is the first step toward de-
monstrating the clinical potential of locomotor training
with a robot providing interactive motion based on volun-
tary drive. The next step would be randomized clinical
studies to compare the efficacy of HAL-assisted training
with that of conventional therapies in terms of improving
walking ability in patients with chronic stroke and to
develop effective operating procedures for using the HAL.
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